Names in the News

The National Association for Behavioral Healthcare (NABH) announced Scott Dziengelski as its new president and CEO on April 13. Dziengelski brings nearly 20 years of experience in health care policy, advocacy and coalition‐building, a news release stated. Most recently, Dziengelski served as a consultant with King & Spalding's FDA & Life Sciences team, where he advocated before Congress and federal agencies — including the U.S. Department of Health and Human Services, the Centers for Medicare & Medicaid Services and the U.S. Food and Drug Administration — on legislative and regulatory issues affecting hospitals, manufacturers, pharmacies and other health care providers. He also serves as an adjunct fellow at the Manhattan Institute, examining policies impacting individuals with serious mental illness and substance use disorders. From 2017 to 2020, Dziengelski was NABH's director of policy and regulatory affairs, helping shape the association's policy agenda. His background also includes service as a legislative director in the U.S. House of Representatives and work with the House Energy and Commerce Committee.